ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FLI1
|
ENSG00000151702.12 | FLI1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FLI1 | hg19_v2_chr11_+_128563948_128564003, hg19_v2_chr11_+_128634589_128634685, hg19_v2_chr11_+_128563652_128563689, hg19_v2_chr11_+_128562372_128562397 | 0.57 | 2.2e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_+_102631844 | 2.81 |
ENST00000372634.1 ENST00000299872.7 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr7_+_93551011 | 2.76 |
ENST00000248564.5 |
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
chr4_+_90816033 | 2.65 |
ENST00000264790.2 ENST00000394981.1 |
MMRN1 |
multimerin 1 |
chrX_+_114827818 | 2.61 |
ENST00000420625.2 |
PLS3 |
plastin 3 |
chr7_+_100770328 | 2.61 |
ENST00000223095.4 ENST00000445463.2 |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
chr3_-_158390282 | 2.55 |
ENST00000264265.3 |
LXN |
latexin |
chrY_+_2709906 | 2.37 |
ENST00000430575.1 |
RPS4Y1 |
ribosomal protein S4, Y-linked 1 |
chr8_+_74903580 | 2.31 |
ENST00000284818.2 ENST00000518893.1 |
LY96 |
lymphocyte antigen 96 |
chr1_+_84609944 | 2.28 |
ENST00000370685.3 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
chr15_+_71185148 | 2.24 |
ENST00000443425.2 ENST00000560755.1 |
LRRC49 |
leucine rich repeat containing 49 |
chr1_-_86043921 | 2.19 |
ENST00000535924.2 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
chr11_-_6341844 | 2.15 |
ENST00000303927.3 |
PRKCDBP |
protein kinase C, delta binding protein |
chrX_+_51546103 | 2.14 |
ENST00000375772.3 |
MAGED1 |
melanoma antigen family D, 1 |
chr4_-_177713788 | 2.12 |
ENST00000280193.2 |
VEGFC |
vascular endothelial growth factor C |
chr14_+_55595762 | 2.08 |
ENST00000254301.9 |
LGALS3 |
lectin, galactoside-binding, soluble, 3 |
chr9_+_116263639 | 2.03 |
ENST00000343817.5 |
RGS3 |
regulator of G-protein signaling 3 |
chrY_+_2709527 | 1.97 |
ENST00000250784.8 |
RPS4Y1 |
ribosomal protein S4, Y-linked 1 |
chr7_-_107643674 | 1.97 |
ENST00000222399.6 |
LAMB1 |
laminin, beta 1 |
chr9_+_116263778 | 1.97 |
ENST00000394646.3 |
RGS3 |
regulator of G-protein signaling 3 |
chr22_-_17680472 | 1.93 |
ENST00000330232.4 |
CECR1 |
cat eye syndrome chromosome region, candidate 1 |
chr1_-_173174681 | 1.91 |
ENST00000367718.1 |
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4 |
chrY_+_22918021 | 1.91 |
ENST00000288666.5 |
RPS4Y2 |
ribosomal protein S4, Y-linked 2 |
chr4_-_57976544 | 1.89 |
ENST00000295666.4 ENST00000537922.1 |
IGFBP7 |
insulin-like growth factor binding protein 7 |
chr15_+_71184931 | 1.86 |
ENST00000560369.1 ENST00000260382.5 |
LRRC49 |
leucine rich repeat containing 49 |
chr14_+_55595960 | 1.85 |
ENST00000554715.1 |
LGALS3 |
lectin, galactoside-binding, soluble, 3 |
chr10_-_126694575 | 1.84 |
ENST00000334808.6 |
CTBP2 |
C-terminal binding protein 2 |
chr20_-_23066953 | 1.83 |
ENST00000246006.4 |
CD93 |
CD93 molecule |
chr12_-_49318715 | 1.82 |
ENST00000444214.2 |
FKBP11 |
FK506 binding protein 11, 19 kDa |
chr2_-_56150184 | 1.80 |
ENST00000394554.1 |
EFEMP1 |
EGF containing fibulin-like extracellular matrix protein 1 |
chrX_-_99891796 | 1.64 |
ENST00000373020.4 |
TSPAN6 |
tetraspanin 6 |
chr6_+_142622991 | 1.60 |
ENST00000230173.6 ENST00000367608.2 |
GPR126 |
G protein-coupled receptor 126 |
chr8_+_22437965 | 1.58 |
ENST00000409141.1 ENST00000265810.4 |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
chr16_+_27325202 | 1.55 |
ENST00000395762.2 ENST00000562142.1 ENST00000561742.1 ENST00000543915.2 ENST00000449195.1 ENST00000380922.3 ENST00000563002.1 |
IL4R |
interleukin 4 receptor |
chrX_+_135230712 | 1.51 |
ENST00000535737.1 |
FHL1 |
four and a half LIM domains 1 |
chr11_+_5710919 | 1.48 |
ENST00000379965.3 ENST00000425490.1 |
TRIM22 |
tripartite motif containing 22 |
chr4_-_16900410 | 1.48 |
ENST00000304523.5 |
LDB2 |
LIM domain binding 2 |
chr20_+_19867150 | 1.47 |
ENST00000255006.6 |
RIN2 |
Ras and Rab interactor 2 |
chr11_-_89224508 | 1.46 |
ENST00000525196.1 |
NOX4 |
NADPH oxidase 4 |
chr5_-_94417339 | 1.45 |
ENST00000429576.2 ENST00000508509.1 ENST00000510732.1 |
MCTP1 |
multiple C2 domains, transmembrane 1 |
chr4_-_16900242 | 1.45 |
ENST00000502640.1 ENST00000506732.1 |
LDB2 |
LIM domain binding 2 |
chr8_+_22438009 | 1.43 |
ENST00000409417.1 |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
chr4_-_16900184 | 1.39 |
ENST00000515064.1 |
LDB2 |
LIM domain binding 2 |
chr4_-_16900217 | 1.39 |
ENST00000441778.2 |
LDB2 |
LIM domain binding 2 |
chr7_+_150264365 | 1.38 |
ENST00000255945.2 ENST00000461940.1 |
GIMAP4 |
GTPase, IMAP family member 4 |
chr11_-_104034827 | 1.37 |
ENST00000393158.2 |
PDGFD |
platelet derived growth factor D |
chr1_+_158978768 | 1.35 |
ENST00000447473.2 |
IFI16 |
interferon, gamma-inducible protein 16 |
chr5_+_140739537 | 1.34 |
ENST00000522605.1 |
PCDHGB2 |
protocadherin gamma subfamily B, 2 |
chr11_-_89224638 | 1.34 |
ENST00000535633.1 ENST00000263317.4 |
NOX4 |
NADPH oxidase 4 |
chr16_+_66400533 | 1.33 |
ENST00000341529.3 |
CDH5 |
cadherin 5, type 2 (vascular endothelium) |
chr2_+_37571717 | 1.29 |
ENST00000338415.3 ENST00000404976.1 |
QPCT |
glutaminyl-peptide cyclotransferase |
chr7_+_134551583 | 1.24 |
ENST00000435928.1 |
CALD1 |
caldesmon 1 |
chrX_+_152086373 | 1.22 |
ENST00000318529.8 |
ZNF185 |
zinc finger protein 185 (LIM domain) |
chr2_+_118846008 | 1.20 |
ENST00000245787.4 |
INSIG2 |
insulin induced gene 2 |
chr1_-_20812690 | 1.19 |
ENST00000375078.3 |
CAMK2N1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr1_+_158975744 | 1.19 |
ENST00000426592.2 |
IFI16 |
interferon, gamma-inducible protein 16 |
chr6_-_33267101 | 1.19 |
ENST00000497454.1 |
RGL2 |
ral guanine nucleotide dissociation stimulator-like 2 |
chr2_+_191208196 | 1.18 |
ENST00000392329.2 ENST00000322522.4 ENST00000430311.1 ENST00000541441.1 |
INPP1 |
inositol polyphosphate-1-phosphatase |
chr12_+_66217911 | 1.18 |
ENST00000403681.2 |
HMGA2 |
high mobility group AT-hook 2 |
chr1_-_23504176 | 1.17 |
ENST00000302291.4 |
LUZP1 |
leucine zipper protein 1 |
chr3_-_127541194 | 1.17 |
ENST00000453507.2 |
MGLL |
monoglyceride lipase |
chr9_-_130617029 | 1.15 |
ENST00000373203.4 |
ENG |
endoglin |
chr13_-_29069232 | 1.14 |
ENST00000282397.4 ENST00000541932.1 ENST00000539099.1 |
FLT1 |
fms-related tyrosine kinase 1 |
chr1_+_169077172 | 1.14 |
ENST00000499679.3 |
ATP1B1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr4_+_2814011 | 1.11 |
ENST00000502260.1 ENST00000435136.2 |
SH3BP2 |
SH3-domain binding protein 2 |
chr22_-_36236265 | 1.11 |
ENST00000414461.2 ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr2_-_188312971 | 1.11 |
ENST00000410068.1 ENST00000447403.1 ENST00000410102.1 |
CALCRL |
calcitonin receptor-like |
chr2_+_37571845 | 1.10 |
ENST00000537448.1 |
QPCT |
glutaminyl-peptide cyclotransferase |
chr14_-_89883412 | 1.10 |
ENST00000557258.1 |
FOXN3 |
forkhead box N3 |
chr12_-_10251576 | 1.09 |
ENST00000315330.4 |
CLEC1A |
C-type lectin domain family 1, member A |
chr1_-_201476274 | 1.09 |
ENST00000340006.2 |
CSRP1 |
cysteine and glycine-rich protein 1 |
chr12_+_75874984 | 1.08 |
ENST00000550491.1 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr9_-_130616915 | 1.08 |
ENST00000344849.3 |
ENG |
endoglin |
chr18_+_51795774 | 1.08 |
ENST00000579534.1 ENST00000406285.3 ENST00000577612.1 ENST00000579434.1 ENST00000583136.1 |
POLI |
polymerase (DNA directed) iota |
chrX_+_54834791 | 1.07 |
ENST00000218439.4 ENST00000375058.1 ENST00000375060.1 |
MAGED2 |
melanoma antigen family D, 2 |
chrY_+_22737678 | 1.07 |
ENST00000382772.3 |
EIF1AY |
eukaryotic translation initiation factor 1A, Y-linked |
chr11_+_47236489 | 1.07 |
ENST00000256996.4 ENST00000378603.3 ENST00000378600.3 ENST00000378601.3 |
DDB2 |
damage-specific DNA binding protein 2, 48kDa |
chr9_-_75567962 | 1.06 |
ENST00000297785.3 ENST00000376939.1 |
ALDH1A1 |
aldehyde dehydrogenase 1 family, member A1 |
chr16_+_56716336 | 1.05 |
ENST00000394485.4 ENST00000562939.1 |
MT1X |
metallothionein 1X |
chr12_-_10251603 | 1.04 |
ENST00000457018.2 |
CLEC1A |
C-type lectin domain family 1, member A |
chr17_-_62097904 | 1.03 |
ENST00000583366.1 |
ICAM2 |
intercellular adhesion molecule 2 |
chr8_+_38677850 | 1.03 |
ENST00000518809.1 ENST00000520611.1 |
TACC1 |
transforming, acidic coiled-coil containing protein 1 |
chr14_-_100842588 | 1.02 |
ENST00000556645.1 ENST00000556209.1 ENST00000556504.1 ENST00000556435.1 ENST00000554772.1 ENST00000553581.1 ENST00000553769.2 ENST00000554605.1 ENST00000557722.1 ENST00000553413.1 ENST00000553524.1 ENST00000358655.4 |
WARS |
tryptophanyl-tRNA synthetase |
chrX_-_140271249 | 1.02 |
ENST00000370526.2 |
LDOC1 |
leucine zipper, down-regulated in cancer 1 |
chr9_+_123970052 | 1.02 |
ENST00000373823.3 |
GSN |
gelsolin |
chr11_-_76381029 | 1.02 |
ENST00000407242.2 ENST00000421973.1 |
LRRC32 |
leucine rich repeat containing 32 |
chr4_-_114900831 | 1.01 |
ENST00000315366.7 |
ARSJ |
arylsulfatase family, member J |
chr20_-_4795747 | 1.01 |
ENST00000379376.2 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
chr2_+_30369807 | 1.00 |
ENST00000379520.3 ENST00000379519.3 ENST00000261353.4 |
YPEL5 |
yippee-like 5 (Drosophila) |
chr7_+_89783689 | 1.00 |
ENST00000297205.2 |
STEAP1 |
six transmembrane epithelial antigen of the prostate 1 |
chr4_-_5021164 | 1.00 |
ENST00000506508.1 ENST00000509419.1 ENST00000307746.4 |
CYTL1 |
cytokine-like 1 |
chr4_+_2813946 | 1.00 |
ENST00000442312.2 |
SH3BP2 |
SH3-domain binding protein 2 |
chr14_+_69865401 | 1.00 |
ENST00000556605.1 ENST00000336643.5 ENST00000031146.4 |
SLC39A9 |
solute carrier family 39, member 9 |
chr16_-_28937027 | 1.00 |
ENST00000358201.4 |
RABEP2 |
rabaptin, RAB GTPase binding effector protein 2 |
chr12_-_133405288 | 0.99 |
ENST00000204726.3 |
GOLGA3 |
golgin A3 |
chr14_+_85996471 | 0.99 |
ENST00000330753.4 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
chr7_-_150329421 | 0.98 |
ENST00000493969.1 ENST00000328902.5 |
GIMAP6 |
GTPase, IMAP family member 6 |
chr17_-_79818354 | 0.98 |
ENST00000576541.1 ENST00000576380.1 ENST00000571617.1 ENST00000576052.1 ENST00000576390.1 ENST00000573778.2 ENST00000439918.2 ENST00000574914.1 ENST00000331483.4 |
P4HB |
prolyl 4-hydroxylase, beta polypeptide |
chr1_-_150780757 | 0.98 |
ENST00000271651.3 |
CTSK |
cathepsin K |
chr9_+_706842 | 0.98 |
ENST00000382293.3 |
KANK1 |
KN motif and ankyrin repeat domains 1 |
chr14_+_24702127 | 0.98 |
ENST00000557854.1 ENST00000348719.7 ENST00000559104.1 ENST00000456667.3 |
GMPR2 |
guanosine monophosphate reductase 2 |
chr22_-_36220420 | 0.97 |
ENST00000473487.2 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chrX_-_10851762 | 0.97 |
ENST00000380785.1 ENST00000380787.1 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
chr3_-_121468513 | 0.97 |
ENST00000494517.1 ENST00000393667.3 |
GOLGB1 |
golgin B1 |
chr3_-_105588231 | 0.97 |
ENST00000545639.1 ENST00000394027.3 ENST00000438603.1 ENST00000447441.1 ENST00000443752.1 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
chr12_-_6798523 | 0.97 |
ENST00000319770.3 |
ZNF384 |
zinc finger protein 384 |
chr11_-_76381781 | 0.96 |
ENST00000260061.5 ENST00000404995.1 |
LRRC32 |
leucine rich repeat containing 32 |
chr3_-_121379739 | 0.95 |
ENST00000428394.2 ENST00000314583.3 |
HCLS1 |
hematopoietic cell-specific Lyn substrate 1 |
chr6_+_76458909 | 0.95 |
ENST00000369981.3 ENST00000369985.4 |
MYO6 |
myosin VI |
chr11_-_104035088 | 0.95 |
ENST00000302251.5 |
PDGFD |
platelet derived growth factor D |
chr22_+_47158578 | 0.94 |
ENST00000355704.3 |
TBC1D22A |
TBC1 domain family, member 22A |
chr18_-_21977748 | 0.93 |
ENST00000399441.4 ENST00000319481.3 |
OSBPL1A |
oxysterol binding protein-like 1A |
chr12_-_10251539 | 0.93 |
ENST00000420265.2 |
CLEC1A |
C-type lectin domain family 1, member A |
chr10_+_63661053 | 0.93 |
ENST00000279873.7 |
ARID5B |
AT rich interactive domain 5B (MRF1-like) |
chr3_+_148583043 | 0.92 |
ENST00000296046.3 |
CPA3 |
carboxypeptidase A3 (mast cell) |
chr2_+_138722028 | 0.91 |
ENST00000280096.5 |
HNMT |
histamine N-methyltransferase |
chr12_-_6798616 | 0.91 |
ENST00000355772.4 ENST00000417772.3 ENST00000396801.3 ENST00000396799.2 |
ZNF384 |
zinc finger protein 384 |
chr15_+_83776324 | 0.90 |
ENST00000379390.6 ENST00000379386.4 ENST00000565774.1 ENST00000565982.1 |
TM6SF1 |
transmembrane 6 superfamily member 1 |
chr3_-_121468602 | 0.90 |
ENST00000340645.5 |
GOLGB1 |
golgin B1 |
chr12_+_56915776 | 0.90 |
ENST00000550726.1 ENST00000542360.1 |
RBMS2 |
RNA binding motif, single stranded interacting protein 2 |
chr12_-_6798410 | 0.90 |
ENST00000361959.3 ENST00000436774.2 ENST00000544482.1 |
ZNF384 |
zinc finger protein 384 |
chr9_+_71736177 | 0.89 |
ENST00000606364.1 ENST00000453658.2 |
TJP2 |
tight junction protein 2 |
chr17_+_66508537 | 0.89 |
ENST00000392711.1 ENST00000585427.1 ENST00000589228.1 ENST00000536854.2 ENST00000588702.1 ENST00000589309.1 |
PRKAR1A |
protein kinase, cAMP-dependent, regulatory, type I, alpha |
chr6_+_3849584 | 0.89 |
ENST00000380274.1 ENST00000380272.3 |
FAM50B |
family with sequence similarity 50, member B |
chr14_+_24702073 | 0.88 |
ENST00000399440.2 |
GMPR2 |
guanosine monophosphate reductase 2 |
chr17_-_62097927 | 0.88 |
ENST00000578313.1 ENST00000584084.1 ENST00000579788.1 ENST00000579687.1 ENST00000578379.1 ENST00000578892.1 ENST00000412356.1 ENST00000418105.1 |
ICAM2 |
intercellular adhesion molecule 2 |
chr2_-_24583583 | 0.88 |
ENST00000355123.4 |
ITSN2 |
intersectin 2 |
chr10_-_33247124 | 0.88 |
ENST00000414670.1 ENST00000302278.3 ENST00000374956.4 ENST00000488494.1 ENST00000417122.2 ENST00000474568.1 |
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
chr4_+_6576895 | 0.88 |
ENST00000285599.3 ENST00000504248.1 ENST00000505907.1 |
MAN2B2 |
mannosidase, alpha, class 2B, member 2 |
chr10_+_31610064 | 0.88 |
ENST00000446923.2 ENST00000559476.1 |
ZEB1 |
zinc finger E-box binding homeobox 1 |
chr14_+_55034330 | 0.87 |
ENST00000251091.5 |
SAMD4A |
sterile alpha motif domain containing 4A |
chr6_-_11382478 | 0.87 |
ENST00000397378.3 ENST00000513989.1 ENST00000508546.1 ENST00000504387.1 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
chr14_+_100842735 | 0.87 |
ENST00000554998.1 ENST00000402312.3 ENST00000335290.6 ENST00000554175.1 |
WDR25 |
WD repeat domain 25 |
chr6_-_112115074 | 0.87 |
ENST00000368667.2 |
FYN |
FYN oncogene related to SRC, FGR, YES |
chr6_-_75994536 | 0.87 |
ENST00000475111.2 ENST00000230461.6 |
TMEM30A |
transmembrane protein 30A |
chr19_+_15218180 | 0.86 |
ENST00000342784.2 ENST00000597977.1 ENST00000600440.1 |
SYDE1 |
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
chr14_+_24702099 | 0.86 |
ENST00000420554.2 |
GMPR2 |
guanosine monophosphate reductase 2 |
chr8_+_38585704 | 0.86 |
ENST00000519416.1 ENST00000520615.1 |
TACC1 |
transforming, acidic coiled-coil containing protein 1 |
chr3_-_57583052 | 0.86 |
ENST00000496292.1 ENST00000489843.1 |
ARF4 |
ADP-ribosylation factor 4 |
chr19_-_48753104 | 0.86 |
ENST00000447740.2 |
CARD8 |
caspase recruitment domain family, member 8 |
chr2_+_33661382 | 0.85 |
ENST00000402538.3 |
RASGRP3 |
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
chr19_-_48752812 | 0.83 |
ENST00000359009.4 |
CARD8 |
caspase recruitment domain family, member 8 |
chr12_+_75874580 | 0.83 |
ENST00000456650.3 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr22_-_43040515 | 0.83 |
ENST00000361740.4 |
CYB5R3 |
cytochrome b5 reductase 3 |
chr3_+_50284321 | 0.83 |
ENST00000451956.1 |
GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
chr18_+_39535152 | 0.83 |
ENST00000262039.4 ENST00000398870.3 ENST00000586545.1 |
PIK3C3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
chr9_-_21974820 | 0.82 |
ENST00000579122.1 ENST00000498124.1 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
chr3_-_18480260 | 0.82 |
ENST00000454909.2 |
SATB1 |
SATB homeobox 1 |
chrY_+_22737604 | 0.82 |
ENST00000361365.2 |
EIF1AY |
eukaryotic translation initiation factor 1A, Y-linked |
chr3_-_57583130 | 0.82 |
ENST00000303436.6 |
ARF4 |
ADP-ribosylation factor 4 |
chr12_+_56915713 | 0.82 |
ENST00000262031.5 ENST00000552247.2 |
RBMS2 |
RNA binding motif, single stranded interacting protein 2 |
chr16_+_1578674 | 0.81 |
ENST00000253934.5 |
TMEM204 |
transmembrane protein 204 |
chr1_+_40505891 | 0.81 |
ENST00000372797.3 ENST00000372802.1 ENST00000449311.1 |
CAP1 |
CAP, adenylate cyclase-associated protein 1 (yeast) |
chr14_+_55033815 | 0.81 |
ENST00000554335.1 |
SAMD4A |
sterile alpha motif domain containing 4A |
chr16_+_1583567 | 0.81 |
ENST00000566264.1 |
TMEM204 |
transmembrane protein 204 |
chr19_+_16296191 | 0.80 |
ENST00000589852.1 ENST00000263384.7 ENST00000588367.1 ENST00000587351.1 |
FAM32A |
family with sequence similarity 32, member A |
chr11_+_71791849 | 0.80 |
ENST00000423494.2 ENST00000539587.1 ENST00000538478.1 ENST00000324866.7 ENST00000439209.1 |
LRTOMT |
leucine rich transmembrane and O-methyltransferase domain containing |
chr11_+_20044600 | 0.79 |
ENST00000311043.8 |
NAV2 |
neuron navigator 2 |
chr13_-_40177261 | 0.79 |
ENST00000379589.3 |
LHFP |
lipoma HMGIC fusion partner |
chr1_-_36789755 | 0.78 |
ENST00000270824.1 |
EVA1B |
eva-1 homolog B (C. elegans) |
chr1_+_40506392 | 0.78 |
ENST00000414893.1 ENST00000414281.1 ENST00000420216.1 ENST00000372792.2 ENST00000372798.1 ENST00000340450.3 ENST00000372805.3 ENST00000435719.1 ENST00000427843.1 ENST00000417287.1 ENST00000424977.1 ENST00000446031.1 |
CAP1 |
CAP, adenylate cyclase-associated protein 1 (yeast) |
chr17_-_33864772 | 0.78 |
ENST00000361112.4 |
SLFN12L |
schlafen family member 12-like |
chr12_+_96588143 | 0.78 |
ENST00000228741.3 ENST00000547249.1 |
ELK3 |
ELK3, ETS-domain protein (SRF accessory protein 2) |
chr10_+_129705299 | 0.78 |
ENST00000254667.3 |
PTPRE |
protein tyrosine phosphatase, receptor type, E |
chr22_+_50312274 | 0.77 |
ENST00000404488.3 |
CRELD2 |
cysteine-rich with EGF-like domains 2 |
chr20_+_44746939 | 0.77 |
ENST00000372276.3 |
CD40 |
CD40 molecule, TNF receptor superfamily member 5 |
chr17_+_4843654 | 0.77 |
ENST00000575111.1 |
RNF167 |
ring finger protein 167 |
chr22_+_50312379 | 0.77 |
ENST00000407217.3 ENST00000403427.3 |
CRELD2 |
cysteine-rich with EGF-like domains 2 |
chr13_-_49001034 | 0.75 |
ENST00000345941.2 |
LPAR6 |
lysophosphatidic acid receptor 6 |
chr15_-_90234006 | 0.75 |
ENST00000300056.3 ENST00000559170.1 |
PEX11A |
peroxisomal biogenesis factor 11 alpha |
chr5_+_140864649 | 0.75 |
ENST00000306593.1 |
PCDHGC4 |
protocadherin gamma subfamily C, 4 |
chr1_-_59043166 | 0.75 |
ENST00000371225.2 |
TACSTD2 |
tumor-associated calcium signal transducer 2 |
chr12_+_53693466 | 0.74 |
ENST00000267103.5 ENST00000548632.1 |
C12orf10 |
chromosome 12 open reading frame 10 |
chr18_-_52989217 | 0.74 |
ENST00000570287.2 |
TCF4 |
transcription factor 4 |
chr3_+_61547585 | 0.73 |
ENST00000295874.10 ENST00000474889.1 |
PTPRG |
protein tyrosine phosphatase, receptor type, G |
chr12_-_105630016 | 0.73 |
ENST00000258530.3 |
APPL2 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
chr2_+_138721850 | 0.73 |
ENST00000329366.4 ENST00000280097.3 |
HNMT |
histamine N-methyltransferase |
chr12_-_105629852 | 0.73 |
ENST00000551662.1 ENST00000553097.1 |
APPL2 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
chr6_+_52535878 | 0.73 |
ENST00000211314.4 |
TMEM14A |
transmembrane protein 14A |
chr5_-_146781153 | 0.72 |
ENST00000520473.1 |
DPYSL3 |
dihydropyrimidinase-like 3 |
chr12_-_50616382 | 0.72 |
ENST00000552783.1 |
LIMA1 |
LIM domain and actin binding 1 |
chr6_-_52441713 | 0.72 |
ENST00000182527.3 |
TRAM2 |
translocation associated membrane protein 2 |
chr1_+_15480197 | 0.72 |
ENST00000400796.3 ENST00000434578.2 ENST00000376008.2 |
TMEM51 |
transmembrane protein 51 |
chr16_-_89556942 | 0.72 |
ENST00000301030.4 |
ANKRD11 |
ankyrin repeat domain 11 |
chr18_-_52989525 | 0.71 |
ENST00000457482.3 |
TCF4 |
transcription factor 4 |
chr8_-_131455835 | 0.71 |
ENST00000518721.1 |
ASAP1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
chr2_+_231280908 | 0.70 |
ENST00000427101.2 ENST00000432979.1 |
SP100 |
SP100 nuclear antigen |
chr22_+_50312316 | 0.70 |
ENST00000328268.4 |
CRELD2 |
cysteine-rich with EGF-like domains 2 |
chr7_-_151574191 | 0.70 |
ENST00000287878.4 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
chr17_+_66508154 | 0.70 |
ENST00000358598.2 |
PRKAR1A |
protein kinase, cAMP-dependent, regulatory, type I, alpha |
chr22_+_31002779 | 0.70 |
ENST00000215838.3 |
TCN2 |
transcobalamin II |
chr14_+_85996507 | 0.70 |
ENST00000554746.1 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
chr18_-_47808050 | 0.70 |
ENST00000590208.1 |
MBD1 |
methyl-CpG binding domain protein 1 |
chr2_-_69870747 | 0.69 |
ENST00000409068.1 |
AAK1 |
AP2 associated kinase 1 |
chr16_+_57653989 | 0.69 |
ENST00000567835.1 ENST00000569372.1 ENST00000563548.1 ENST00000562003.1 |
GPR56 |
G protein-coupled receptor 56 |
chr6_-_169654139 | 0.69 |
ENST00000366787.3 |
THBS2 |
thrombospondin 2 |
chr3_-_52002403 | 0.68 |
ENST00000490063.1 ENST00000468324.1 ENST00000497653.1 ENST00000484633.1 |
PCBP4 |
poly(rC) binding protein 4 |
chr2_+_31456874 | 0.68 |
ENST00000541626.1 |
EHD3 |
EH-domain containing 3 |
chr15_-_90233866 | 0.67 |
ENST00000561257.1 |
PEX11A |
peroxisomal biogenesis factor 11 alpha |
chr10_+_75545391 | 0.67 |
ENST00000604524.1 ENST00000605216.1 ENST00000398706.2 |
ZSWIM8 |
zinc finger, SWIM-type containing 8 |
chr4_-_90759440 | 0.67 |
ENST00000336904.3 |
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.7 | 2.0 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.6 | 3.9 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.6 | 2.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 1.6 | GO:0055028 | cortical microtubule(GO:0055028) mitotic spindle astral microtubule(GO:0061673) |
0.5 | 1.4 | GO:0034680 | integrin alpha3-beta1 complex(GO:0034667) integrin alpha8-beta1 complex(GO:0034678) integrin alpha10-beta1 complex(GO:0034680) |
0.3 | 1.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 1.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 1.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 0.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.3 | 0.8 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.2 | 0.7 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.2 | 0.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 1.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 0.6 | GO:0044609 | DBIRD complex(GO:0044609) |
0.2 | 0.6 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
0.2 | 1.4 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.0 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 3.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 2.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 3.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.7 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 0.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) outer acrosomal membrane(GO:0002081) |
0.2 | 2.3 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.0 | GO:0070522 | nucleotide-excision repair factor 1 complex(GO:0000110) ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 1.7 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 1.0 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.7 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.4 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.1 | 0.5 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 1.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.8 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 0.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 1.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.4 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 1.4 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 0.4 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 7.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.2 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.1 | 0.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.3 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.1 | 0.3 | GO:0032044 | DSIF complex(GO:0032044) |
0.1 | 0.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 0.4 | GO:0045240 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 1.5 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.1 | 0.5 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 1.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 5.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 1.7 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 0.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 1.3 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.2 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 0.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 1.5 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 3.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 3.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.6 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 6.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 7.1 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.6 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.4 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.4 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 1.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 2.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 2.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.7 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.0 | 3.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 1.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 1.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 1.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.4 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 2.9 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.6 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 2.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.7 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.7 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 1.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 13.2 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 5.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.2 | GO:0036452 | ESCRT complex(GO:0036452) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.2 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
0.0 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.0 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.0 | 0.2 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 1.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 1.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.2 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.5 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 1.3 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 1.7 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.0 | 0.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.8 | GO:0001300 | chronological cell aging(GO:0001300) |
1.3 | 3.9 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
0.8 | 2.4 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.7 | 2.2 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.7 | 3.4 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.5 | 1.6 | GO:0071988 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.5 | 0.5 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.5 | 2.0 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.5 | 2.3 | GO:0097338 | response to clozapine(GO:0097338) |
0.5 | 0.5 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.4 | 2.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.4 | 2.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.4 | 1.2 | GO:0035978 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.4 | 1.1 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.4 | 1.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 1.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.3 | 2.7 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.3 | 1.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 1.3 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
0.3 | 0.9 | GO:0033242 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.3 | 2.4 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
0.3 | 0.9 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.3 | 1.4 | GO:0010710 | calcium-independent cell-matrix adhesion(GO:0007161) regulation of collagen catabolic process(GO:0010710) |
0.3 | 1.1 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) positive regulation of potassium ion import(GO:1903288) |
0.3 | 1.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 1.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 1.9 | GO:0051414 | response to cortisol(GO:0051414) |
0.3 | 2.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.3 | 0.5 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.3 | 0.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 1.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 2.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.7 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.2 | 5.9 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.2 | 3.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 1.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 2.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.2 | 1.0 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.2 | 1.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 1.0 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.2 | 0.6 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.2 | 2.2 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 0.8 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 0.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.6 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.2 | 1.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.7 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.7 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.2 | 0.5 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.2 | 1.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 0.5 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.2 | 1.7 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.2 | 1.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.2 | 1.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 1.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.8 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.2 | 2.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.8 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 0.5 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.2 | 2.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.2 | 1.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 1.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 0.5 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.1 | 0.7 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.1 | 0.6 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.1 | 0.6 | GO:0009956 | radial pattern formation(GO:0009956) |
0.1 | 1.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 1.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.6 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.7 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.1 | 1.0 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 2.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 3.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.7 | GO:0044783 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) DNA damage response, signal transduction by p53 class mediator(GO:0030330) mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.1 | 1.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.7 | GO:1903285 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
0.1 | 0.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 0.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 0.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.4 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.1 | 0.4 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.1 | 0.1 | GO:0072666 | protein targeting to vacuole(GO:0006623) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 0.6 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.7 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 0.1 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.1 | 1.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.6 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 0.6 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
0.1 | 1.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 1.6 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.3 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.1 | 0.9 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 1.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 1.2 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.1 | 0.8 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 0.1 | GO:0051057 | positive regulation of Ras protein signal transduction(GO:0046579) positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.1 | 1.2 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.1 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 4.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.7 | GO:1900045 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.9 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.8 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.4 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 2.1 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.3 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.1 | 0.3 | GO:0050894 | determination of affect(GO:0050894) |
0.1 | 0.3 | GO:1902309 | regulation of heart rate by hormone(GO:0003064) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.3 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.1 | 0.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 0.3 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.4 | GO:0006041 | glucosamine metabolic process(GO:0006041) glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.8 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.1 | 0.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.7 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.4 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.6 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 1.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.2 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 1.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 0.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.6 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 1.0 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.1 | 2.7 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.5 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.4 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of lung blood pressure(GO:0061767) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.1 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.4 | GO:0031022 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear migration along microfilament(GO:0031022) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.3 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
0.1 | 0.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 1.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.1 | 0.8 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 2.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.4 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.5 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.8 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 1.6 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 1.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.2 | GO:0044242 | cellular lipid catabolic process(GO:0044242) |
0.1 | 0.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 1.7 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.1 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
0.1 | 0.1 | GO:0002877 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.1 | 0.3 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.9 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.6 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.1 | 0.2 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.1 | 0.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.2 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.4 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.7 | GO:0050890 | cognition(GO:0050890) |
0.1 | 0.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.8 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.3 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 2.1 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.5 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
0.1 | 0.2 | GO:2000705 | dense core granule biogenesis(GO:0061110) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 1.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.8 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.1 | 0.4 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.1 | 0.2 | GO:0097576 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.1 | 0.4 | GO:0050703 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.3 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.0 | 0.4 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.0 | 0.8 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.2 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.0 | 0.1 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
0.0 | 0.3 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.0 | 1.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.0 | 0.2 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
0.0 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.2 | GO:0021997 | neural plate axis specification(GO:0021997) |
0.0 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 1.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.7 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 1.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.0 | 0.2 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.0 | 0.5 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.3 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.0 | 1.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 1.9 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.7 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.2 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.0 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.0 | 0.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 1.8 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.3 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.0 | GO:1990564 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.3 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.0 | 0.4 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.0 | 0.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.7 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 1.9 | GO:0042116 | macrophage activation(GO:0042116) |
0.0 | 0.6 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.2 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.0 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 2.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.0 | 1.5 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.4 | GO:0006516 | N-acetylglucosamine metabolic process(GO:0006044) glycoprotein catabolic process(GO:0006516) |
0.0 | 0.4 | GO:0007127 | meiosis I(GO:0007127) |
0.0 | 0.3 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 4.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 1.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.4 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.2 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.0 | 0.1 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.0 | 0.5 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.2 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.0 | 0.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 1.5 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.0 | 0.2 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 0.8 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.0 | 1.0 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.8 | GO:0016577 | histone demethylation(GO:0016577) |
0.0 | 0.8 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.0 | 0.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.8 | GO:0042060 | wound healing(GO:0042060) |
0.0 | 0.8 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.1 | GO:0060666 | pulmonary myocardium development(GO:0003350) dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.4 | GO:0006914 | autophagy(GO:0006914) |
0.0 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.5 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.0 | 0.2 | GO:0008361 | regulation of cell size(GO:0008361) |
0.0 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.0 | 0.1 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.0 | 0.4 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.1 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.2 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.3 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.2 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.5 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.5 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.8 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.1 | GO:0060179 | courtship behavior(GO:0007619) male mating behavior(GO:0060179) |
0.0 | 0.6 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.0 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.0 | 0.0 | GO:0098904 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) regulation of AV node cell action potential(GO:0098904) regulation of bundle of His cell action potential(GO:0098905) regulation of renin secretion into blood stream(GO:1900133) |
0.0 | 0.5 | GO:0006897 | endocytosis(GO:0006897) |
0.0 | 0.3 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.0 | 1.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.4 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.2 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.0 | 0.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.2 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.5 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.3 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.1 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 1.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.0 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.0 | 0.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.3 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 1.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.3 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.0 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.0 | 0.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.1 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.6 | 3.9 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.6 | 0.6 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.6 | 1.7 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.5 | 5.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 3.9 | GO:0019863 | IgE binding(GO:0019863) |
0.5 | 0.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.4 | 2.2 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.4 | 1.2 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.4 | 1.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 1.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 1.0 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.3 | 0.9 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.3 | 2.8 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.3 | 2.2 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 1.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 1.9 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.3 | 2.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 1.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 2.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 1.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 1.0 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 1.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 1.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 1.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.2 | 0.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.7 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 1.1 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.2 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 3.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 0.6 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.6 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 1.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 1.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 2.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 1.0 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.4 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.1 | 0.7 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.1 | 0.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 0.3 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.1 | 1.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 2.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 3.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.8 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 1.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 2.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 1.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.1 | 1.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.3 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 0.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 2.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.6 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 1.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.3 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.1 | 0.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 1.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.3 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.1 | 0.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 5.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 1.0 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.5 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.2 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 2.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.9 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.6 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 1.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 1.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.1 | 0.6 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.1 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 1.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 2.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 2.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.8 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 1.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 1.0 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.9 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 1.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.0 | 1.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.0 | 4.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 1.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.1 | GO:0004769 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.2 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 1.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.3 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.6 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.1 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.0 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.2 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 1.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 1.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 2.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.1 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
0.0 | 0.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.0 | 0.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 0.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 1.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 5.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 1.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 7.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 2.9 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.5 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.9 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 1.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.0 | 1.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.4 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 1.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.8 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 6.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 3.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 3.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 2.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 3.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.3 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.9 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 4.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 2.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 1.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 1.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 1.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 1.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 2.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 4.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 2.2 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 1.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 1.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.7 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 1.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 6.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 5.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 2.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 9.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 4.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 2.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 2.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 2.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 2.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 1.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 2.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 6.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 3.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 2.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 3.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |